Genetic research ties weight loss drugs to baldness

A genetic study has shown that the use of weight loss medications such as "Ozempic" is associated with a slight increase of 7% in the risk of hereditary baldness in men who carry certain genes that enhance levels of "GLP-1" receptors. The study indicated that the drug's effect might be partly genetic, as higher levels of the receptor associated with the medication are linked to increased chances of hair loss. Relying on genetic analysis allowed researchers to connect the use of slimming drugs with a heightened risk of baldness, although the study did not directly monitor individuals taking these medications.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل